Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-20

Clinical Trial Update: Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study

View source ↗

Summary

A prospective cohort study found that changes in spleen volume during neurocritical care predict 45-day mortality in patients with intracerebral hemorrhage/hemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ankara City Hospital Bilkent | Conditions: Intracerebral Hemorrhage (ICH), Hemorrhagic Stroke, Intracerebral | Status: COMPLETED